QVJ499A
Biological
Novartis Pharma AG
Total Payments
$21,057
Transactions
13
Doctors
5
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $16,057 | 12 | 4 |
| 2017 | $5,000 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,664 | 5 | 60.1% |
| Travel and Lodging | $8,230 | 5 | 39.1% |
| Food and Beverage | $162.71 | 3 | 0.8% |
Ad
Manufacturing Companies
- Novartis Pharma AG $21,057
Product Information
- Type Biological
- Total Payments $21,057
- Total Doctors 5
- Transactions 13
About QVJ499A
QVJ499A is a biological associated with $21,057 in payments to 5 healthcare providers, recorded across 13 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2017 to 2018. In 2018, $16,057 was paid across 12 transactions to 4 doctors.
The most common payment nature for QVJ499A is "Consulting Fee" ($12,664, 60.1% of total).